BiomX to Present at Upcoming March Investor Conferences

Rhea-AI Summary

BiomX (NYSE American: PHGE), a clinical-stage biotechnology company, announced that CEO Jonathan Solomon will present at two virtual investor conferences in March 2021. The first event is Chardan’s 3rd Annual Microbiome Medicines Summit on March 8, 2021, at 10:45 AM EST. The second is H.C. Wainwright's Global Life Sciences Conference on March 9, 2021, with on-demand access starting at 7:00 AM EST. The presentations will be available for streaming on the company’s website, offering insights into BiomX's development of phage therapies targeting specific pathogenic bacteria.

BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer, will participate in two upcoming virtual investor conferences.

Presentation Details:

Event: Chardan’s 3rd Annual Microbiome Medicines Summit
Date: Monday, March 8, 2021
Time: 10:45 AM EST

Event: H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time: On-demand beginning at 7:00 AM EST

Live webcasts from the Chardan and H.C. Wainwright presentations will be accessible through the Investors section of the Company’s website at ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX

BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

Additional information is available at www.biomx.com, the content of which does not form a part of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210301005072/en/

FAQ

When is Jonathan Solomon speaking at the Chardan’s 3rd Annual Microbiome Medicines Summit?

Jonathan Solomon will present at Chardan’s 3rd Annual Microbiome Medicines Summit on March 8, 2021, at 10:45 AM EST.

What time is the H.C. Wainwright Global Life Sciences Conference presentation?

The H.C. Wainwright Global Life Sciences Conference presentation will be available on-demand starting at 7:00 AM EST on March 9, 2021.

Where can I watch the BiomX investor presentations?

You can watch the BiomX investor presentations through the Investors section of the company's website at ir.biomx.com/news-events/ir-calendar.

What type of therapies does BiomX develop?

BiomX develops natural and engineered phage therapies that target specific pathogenic bacteria impacting skin and chronic diseases.

What conditions are targeted by BiomX's phage therapies?

BiomX targets bacteria affecting conditions such as inflammatory bowel disease, cystic fibrosis, and colorectal cancer.